InfuSystem Holdings, Inc. (INFU)
NYSEAMERICAN: INFU · IEX Real-Time Price · USD
6.67
-0.16 (-2.34%)
Jul 2, 2024, 4:00 PM EDT - Market closed

InfuSystem Holdings Revenue

InfuSystem Holdings had revenue of $127.41M in the twelve months ending March 31, 2024, with 12.23% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $32.00M with 5.35% year-over-year growth. In the year 2023, InfuSystem Holdings had annual revenue of $125.79M with 14.44% growth.

Revenue (ttm)
$127.41M
Revenue Growth
+12.23%
P/S Ratio
1.11
Revenue / Employee
$255,331
Employees
499
Market Cap
142.04M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023125.79M15.87M14.44%
Dec 31, 2022109.91M7.53M7.36%
Dec 31, 2021102.38M4.99M5.13%
Dec 31, 202097.39M16.27M20.06%
Dec 31, 201981.12M13.98M20.82%
Dec 31, 201867.14M-3.94M-5.54%
Dec 31, 201771.08M580.00K0.82%
Dec 31, 201670.50M-44.00K-0.06%
Dec 31, 201570.54M4.05M6.10%
Dec 31, 201466.49M4.21M6.75%
Dec 31, 201362.28M3.45M5.87%
Dec 31, 201258.83M4.19M7.67%
Dec 31, 201154.64M7.41M15.69%
Dec 31, 201047.23M8.27M21.21%
Dec 31, 200938.96M3.55M10.02%
Dec 31, 200835.42M28.83M438.06%
Dec 31, 20076.58M--
Dec 31, 20060--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Lifecore Biomedical 103.27M
Repare Therapeutics 97.86M
Caribou Biosciences 33.40M
ClearPoint Neuro 26.16M
Zomedica 25.97M
MediWound 19.85M
Veru Inc. 13.48M
Revenue Rankings